Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs

被引：0
|
作者：
Cormac Sheridan
机构：
[1] Dublin,
[2] Ireland,undefined
来源：
Nature Biotechnology | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：893 / 893
相关论文
共 50 条
  • [1] Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs
    Cormac Sheridan
    Nature Biotechnology, 2021, 39 : 1017 - 1017
  • [2] Questions swirl around failures of disease-modifying Huntington's drugs
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2021, 39 (06) : 650 - 652
  • [3] Questions swirl around failures of disease-modifying Huntington’s drugs
    Cormac Sheridan
    Nature Biotechnology, 2021, 39 : 650 - 652
  • [4] Questions swirl around failures of disease-modifying Huntington's drugs (vol 39, pg 650, 2021)
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2021, 39 (07) : 893 - 893
  • [5] Questions swirl around failures of disease-modifying Huntington's drugs (vol 39, pg 650, 2021)
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2021, 39 (08) : 1017 - 1017
  • [6] Delivering a disease-modifying treatment for Huntington's disease
    Godinho, Bruno M. D. C.
    Malhotra, Meenakshi
    O'Driscoll, Caitriona M.
    Cryan, John F.
    DRUG DISCOVERY TODAY, 2015, 20 (01) : 50 - 64
  • [7] Disease-Modifying Drugs in Parkinson’s Disease
    Ariane Park
    Mark Stacy
    Drugs, 2015, 75 : 2065 - 2071
  • [8] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [9] Disease-modifying drugs in Alzheimer's disease
    Ghezzi, Laura
    Scarpini, Elio
    Galimberti, Daniela
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1471 - 1479
  • [10] Disease-Modifying Drugs in Parkinson's Disease
    Park, Ariane
    Stacy, Mark
    DRUGS, 2015, 75 (18) : 2065 - 2071
12345